Patents by Inventor A. D. Britt
A. D. Britt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9740194Abstract: A machine can be accessed and controlled with the help of an interface device. The customizable interface device contains device elements that define features relating to the external representation and internal functionality of the interface device, as linked to one or more machines. An operator can use a configuration station to implement single or reoccurring queries that interact with the interface device and corresponding machines. In particular, the queries target the configuration of device elements in the interface device. The process can include temporarily unloading unused features from active memory and mirroring property changes initialized by a source. An emulator can assist in the configuration process by providing a preliminary software representation of the interface device hardware. A user can develop, test, and reconfigure functions on the emulator before loading the finalized platform to the interface device.Type: GrantFiled: February 18, 2010Date of Patent: August 22, 2017Assignee: ROCKWELL AUTOMATION TECHNOLOGIES, INC.Inventors: Krista Kummerfeldt Mann, Robert F. Lloyd, Steven Mark Cisler, Clinton D. Britt, Joseph Francis Mann
-
Publication number: 20160095284Abstract: A plurality of similar components for forming a plant covering device for the protection of plants from external adverse weather elements and other hazards. The components are made of a thin sheet of flexible plastic or other material cut into similar two-dimensional component panels allowing many different configurations to be made out of the plurality of components. The individual component panels are provided with a fastening means for joining the separate component panels into a completed assembly. The plant covering device provides an easily assembled, self-supporting structure to be placed over one or more plants or a location. The plant covering device is erected without the use of tools or need for a separate frame or support. The size of the plant covering device may be reconfigured and expanded in width, and/or height, and/or depth using an additional plurality of component panels. The plant covering device may be used with stakes or spikes.Type: ApplicationFiled: October 6, 2014Publication date: April 7, 2016Inventor: Mark D. Britt
-
Patent number: 8691758Abstract: The present invention relates to compounds of formula I or formula Ia or pharmaceutically acceptable salts thereof, that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.Type: GrantFiled: May 15, 2006Date of Patent: April 8, 2014Assignee: Vertex Pharmaceuticals IncorporatedInventors: Shawn D. Britt, Kevin M. Cottrell, Robert B. Perni, Janos Pitlik
-
Publication number: 20130116169Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.Type: ApplicationFiled: June 7, 2012Publication date: May 9, 2013Applicant: VERTEX PHARMACEUTICALS INCORPORATEDInventors: Robert B. Perni, John J. Court, Shawn D. Britt, Janos Pitlik, John H. van Drie
-
Patent number: 8222425Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.Type: GrantFiled: July 19, 2011Date of Patent: July 17, 2012Assignee: Novartis AGInventors: Shawn D. Britt, Lech Andrzej Ciszewski, Jiping Fu, Subramanian Karur, Yugang Liu, Peichao Lu, David Thomas Parker, Mahavir Prashad, Prakash Raman, Pascal Rigollier, Mohindra Seepersaud, Aregahegn Yifru, Rui Zheng
-
Patent number: 8217048Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.Type: GrantFiled: June 28, 2010Date of Patent: July 10, 2012Assignee: Vertex Pharmaceuticals IncorporatedInventors: Robert B. Perni, John J. Court, Shawn D. Britt, Janos Pitlik, John H. van Drie
-
Publication number: 20110275819Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.Type: ApplicationFiled: July 19, 2011Publication date: November 10, 2011Applicant: NOVARTIS AGInventors: Shawn D. BRITT, Lech Andrzej CISZEWSKI, Jiping FU, Subramanian KARUR, Yugang LIU, Peichao LU, David Thomas PARKER, Mahavir PRASHAD, Prakash RAMAN, Pascal RIGOLLIER, Mohindra SEEPERSAUD, Aregahegn YIFRU, Rui ZHENG
-
Patent number: 8008263Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.Type: GrantFiled: October 10, 2008Date of Patent: August 30, 2011Assignee: Novartis AGInventors: Shawn D. Britt, Lech Andrzej Ciszewski, Jiping Fu, Subramanian Karur, Yugang Liu, Peichao Lu, David Thomas Parker, Mahavir Prashad, Prakash Raman, Pascal Rigollier, Mohindra Seepersaud, Aregahegn Yifru, Rui Zheng
-
Publication number: 20110104115Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.Type: ApplicationFiled: June 28, 2010Publication date: May 5, 2011Applicant: VERTEX PHARMACEUTICALS INCOROPRATEDInventors: Robert B. Perni, John J. Court, Shawn D. Britt, Janos Pitlik, John H. Van Drie
-
Publication number: 20100240638Abstract: The present application describes macrocyclic compounds of formula (I) with NS3 protease inhibitory activity for treating hepatitis C virus infection.Type: ApplicationFiled: February 19, 2008Publication date: September 23, 2010Inventors: Shawn D. Britt, Jiping Fu, David Thomas Parker, Michiael Patane, Parkash Raman, Branko Radetich, Mohindra Seepersaud, Aregahegn Yifru, Rui Zheng, Trixi Brand, Sylvain Cottens, Claus Ehrhardt, Stefan Andreas Randl, Pascal Rigollier, Nikolaus Schiering, Oliver Simic
-
Patent number: 7745444Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.Type: GrantFiled: April 10, 2008Date of Patent: June 29, 2010Assignee: Vertex Pharmaceuticals IncorporatedInventors: Robert B. Perni, John J. Court, Shawn D. Britt, Janos Pitlik, John H. van Drie
-
Publication number: 20100146418Abstract: A machine can be accessed and controlled with the help of an interface device. The customizable interface device contains device elements that define features relating to the external representation and internal functionality of the interface device, as linked to one or more machines. An operator can use a configuration station to implement single or reoccurring queries that interact with the interface device and corresponding machines. In particular, the queries target the configuration of device elements in the interface device. The process can include temporarily unloading unused features from active memory and mirroring property changes initialized by a source. An emulator can assist in the configuration process by providing a preliminary software representation of the interface device hardware. A user can develop, test, and reconfigure functions on the emulator before loading the finalized platform to the interface device.Type: ApplicationFiled: February 18, 2010Publication date: June 10, 2010Applicant: ROCKWELL AUTOMATION TECHNOLOGIES, INC.Inventors: Krista Kummerfeldt Mann, Robert F. Lloyd, Steven Mark Cisler, Clinton D. Britt, Joseph Francis Mann
-
Patent number: 7593780Abstract: A machine can be accessed and controlled with the help of an interface device. The customizable interface device contains device elements that define features relating to the external representation and internal functionality of the interface device, as linked to one or more machines. An operator can use a configuration station to implement single or reoccurring queries that interact with the interface device and corresponding machines. In particular, the queries target the configuration of device elements in the interface device. The process can include temporarily unloading unused features from active memory and mirroring property changes initialized by a source. An emulator can assist in the configuration process by providing a preliminary software representation of the interface device hardware. A user can develop, test, and reconfigure functions on the emulator before loading the finalized platform to the interface device.Type: GrantFiled: September 29, 2006Date of Patent: September 22, 2009Assignee: Rockwell Automation Technologies, Inc.Inventors: Krista Kummerfeldt Mann, Robert F. Lloyd, Steven M. Cisler, Clinton D. Britt, Joseph F. Mann
-
Publication number: 20090137495Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.Type: ApplicationFiled: October 10, 2008Publication date: May 28, 2009Inventors: Shawn D. Britt, Lech Andrzej Ciszewski, Jiping Fu, Subramanian Karur, Yugang Liu, Peichao Lu, David Thomas Parker, Mahavir Prashad, Prakash Raman, Pascal Rigollier, Mohindra Seepersaud, Aregahegn Yifru, Rui Zheng
-
Publication number: 20080311079Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.Type: ApplicationFiled: April 10, 2008Publication date: December 18, 2008Applicant: Vertex Pharmaceuticals IncorporatedInventors: Robert B. Perni, John J. Court, Shawn D. Britt, Janos Pitlik, John H. van Drie
-
Patent number: 7378422Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.Type: GrantFiled: September 7, 2004Date of Patent: May 27, 2008Assignee: Vertex Pharmaceuticals IncorporatedInventors: Robert B. Perni, John J. Court, Shawn D. Britt, Janos Pitlik, John H. van Drie
-
Patent number: 7109172Abstract: The present invention relates to compounds of formula I or formula Ia or pharmaceutically acceptable salts thereof, that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3–NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.Type: GrantFiled: July 16, 2004Date of Patent: September 19, 2006Assignee: Vertex Pharmaceuticals IncorporatedInventors: Shawn D. Britt, Kevin M. Cottrell, Robert B. Perni, Janos Pitlik
-
Patent number: 7008177Abstract: A fluid pump including provisions for cooling and/or flushing in the vicinity of a static seal. In one embodiment, the invention includes an open channel fluid passageway defined on a generally flat surface of a pump housing. A centrifugal rotor with a generally flat backplate rotates proximate a surface of the housing. The fluid passageways are adapted and configured to have a pathway that includes a directional component parallel to the direction of rotation, such that fluid drag from the rotating backplate induces flow within the passageway. The passages of the exit can be positioned such that flow exiting the passageway is at least partly tangential to the seal and/or the seal housing.Type: GrantFiled: November 10, 2003Date of Patent: March 7, 2006Assignee: Cummins Inc.Inventors: Timothy D. Britt, Randall J. Stafford, Donald W. Stanton
-
Publication number: 20040136826Abstract: A fluid pump including provisions for cooling and/or flushing in the vicinity of a static seal. In one embodiment, the invention includes an open channel fluid passageway defined on a generally flat surface of a pump housing. A centrifugal rotor with a generally flat backplate rotates proximate a surface of the housing. The fluid passageways are adapted and configured to have a pathway that includes a directional component parallel to the direction of rotation, such that fluid drag from the rotating backplate induces flow within the passageway. The passages of the exit can be positioned such that flow exiting the passageway is at least partly tangential to the seal and/or the seal housing.Type: ApplicationFiled: November 10, 2003Publication date: July 15, 2004Inventors: Timothy D. Britt, Randall J. Stafford, Donald W. Stanton
-
Publication number: 20030095958Abstract: The present invention relates to inhibitors of aspartic proteinases, particularly, BACE. The present invention also relates to compositions thereof and methods therewith for inhibiting BACE activity in a mammal, and for treating Alzheimer's Disease and other BACE-mediated diseases.Type: ApplicationFiled: April 29, 2002Publication date: May 22, 2003Inventors: Govinda R. Bhisetti, Jeffrey O. Saunders, Mark A. Murcko, Christopher A. Lepre, Shawn D. Britt, Jon H. Come, David D. Deininger, Tianshang Wang